Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GLENMARK PHARMA vs SUN PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GLENMARK PHARMA SUN PHARMA GLENMARK PHARMA/
SUN PHARMA
 
P/E (TTM) x -31.3 43.5 - View Chart
P/BV x 2.8 7.0 40.8% View Chart
Dividend Yield % 0.3 0.7 37.1%  

Financials

 GLENMARK PHARMA   SUN PHARMA
EQUITY SHARE DATA
    GLENMARK PHARMA
Mar-23
SUN PHARMA
Mar-23
GLENMARK PHARMA/
SUN PHARMA
5-Yr Chart
Click to enlarge
High Rs4871,072 45.4%   
Low Rs349790 44.2%   
Sales per share (Unadj.) Rs460.4182.9 251.7%  
Earnings per share (Unadj.) Rs13.435.7 37.5%  
Cash flow per share (Unadj.) Rs35.046.2 75.8%  
Dividends per share (Unadj.) Rs2.5011.50 21.7%  
Avg Dividend yield %0.61.2 48.4%  
Book value per share (Unadj.) Rs335.1233.4 143.6%  
Shares outstanding (eoy) m282.172,399.34 11.8%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.95.1 17.8%   
Avg P/E ratio x31.326.1 119.8%  
P/CF ratio (eoy) x11.920.1 59.2%  
Price / Book Value ratio x1.24.0 31.3%  
Dividend payout %18.732.2 58.0%   
Avg Mkt Cap Rs m117,9532,233,361 5.3%   
No. of employees `000NANA-   
Total wages/salary Rs m27,81082,960 33.5%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m129,901438,857 29.6%  
Other income Rs m3,1688,199 38.6%   
Total revenues Rs m133,069447,055 29.8%   
Gross profit Rs m15,125112,900 13.4%  
Depreciation Rs m6,11325,294 24.2%   
Interest Rs m3,4961,720 203.2%   
Profit before tax Rs m8,68594,084 9.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m4,9118,476 57.9%   
Profit after tax Rs m3,77485,608 4.4%  
Gross profit margin %11.625.7 45.3%  
Effective tax rate %56.59.0 627.6%   
Net profit margin %2.919.5 14.9%  
BALANCE SHEET DATA
Current assets Rs m98,737398,619 24.8%   
Current liabilities Rs m50,455199,064 25.3%   
Net working cap to sales %37.245.5 81.7%  
Current ratio x2.02.0 97.7%  
Inventory Days Days7147 4.6%  
Debtors Days Days11595 121.1%  
Net fixed assets Rs m76,920376,960 20.4%   
Share capital Rs m2822,399 11.8%   
"Free" reserves Rs m94,281557,555 16.9%   
Net worth Rs m94,563559,954 16.9%   
Long term debt Rs m38,5210-   
Total assets Rs m175,658775,794 22.6%  
Interest coverage x3.555.7 6.3%   
Debt to equity ratio x0.40-  
Sales to assets ratio x0.70.6 130.7%   
Return on assets %4.111.3 36.8%  
Return on equity %4.015.3 26.1%  
Return on capital %9.217.1 53.5%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m46,464154,053 30.2%   
Fx outflow Rs m12,71271,511 17.8%   
Net fx Rs m33,75182,541 40.9%   
CASH FLOW
From Operations Rs m6,25449,593 12.6%  
From Investments Rs m-5,285-79,437 6.7%  
From Financial Activity Rs m-77523,761 -3.3%  
Net Cashflow Rs m3251,155 28.1%  

Share Holding

Indian Promoters % 46.7 54.5 85.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 34.7 36.6 94.8%  
FIIs % 23.7 17.1 138.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 53.4 45.5 117.2%  
Shareholders   209,931 612,626 34.3%  
Pledged promoter(s) holding % 0.0 2.4 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GLENMARK PHARMA With:   DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    MANKIND PHARMA    


More on Glenmark Pharma vs Sun Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Glenmark Pharma vs Sun Pharma Share Price Performance

Period Glenmark Pharma Sun Pharma S&P BSE HEALTHCARE
1-Day -0.84% 1.45% 1.18%
1-Month 4.88% 3.70% -0.75%
1-Year 112.38% 65.76% 61.82%
3-Year CAGR 27.39% 39.76% 18.16%
5-Year CAGR 8.00% 27.95% 19.79%

* Compound Annual Growth Rate

Here are more details on the Glenmark Pharma share price and the Sun Pharma share price.

Moving on to shareholding structures...

The promoters of Glenmark Pharma hold a 46.7% stake in the company. In case of Sun Pharma the stake stands at 54.5%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Glenmark Pharma and the shareholding pattern of Sun Pharma.

Finally, a word on dividends...

In the most recent financial year, Glenmark Pharma paid a dividend of Rs 2.5 per share. This amounted to a Dividend Payout ratio of 18.7%.

Sun Pharma paid Rs 11.5, and its dividend payout ratio stood at 32.2%.

You may visit here to review the dividend history of Glenmark Pharma, and the dividend history of Sun Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.